News
3h
PRIMETIMER on MSNSerena Williams’ honest confession: Why she started taking Zepbound
Serena Williams opens up about hitting a weight loss plateau and why she turned to Zepbound to achieve her fitness goals.
Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss drug.
Serena Williams reveals a 31-pound weight loss with Zepbound after fan concern, crediting the drug for transforming her ...
Serena Williams finally comes clean about her drastic weight change. She shares she lost 31 pounds through weight loss ...
Serena Williams wants to be transparent and is opening up about her fitness journey, revealing she's taking a GLP-1 ...
1d
24/7 Wall St. on MSNEli Lilly Ranks Among Top Large-Cap Performers as GLP-1 Drug Sales Exceed Billions
Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.
Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...
Employers are about to spend a lot more on health insurance next year as they shoulder higher costs driven by GLP-1 drugs, ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring to U.S. biopharma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results